197 related articles for article (PubMed ID: 35348903)
1. Integrated transcriptomic and proteomic analyses for the characterization of parathyroid oxyphil cells in uremic patients.
Mao J; You H; Wang M; Ni L; Zhang Q; Zhang M; Chen J
Amino Acids; 2022 May; 54(5):749-763. PubMed ID: 35348903
[TBL] [Abstract][Full Text] [Related]
2. Comparative proteomic analysis of chief and oxyphil cell nodules in refractory uremic hyperparathyroidism by iTRAQ coupled LC-MS/MS.
Li S; Mao J; Wang M; Zhang M; Ni L; Tao Y; Huang B; Chen J
J Proteomics; 2018 May; 179():42-52. PubMed ID: 29526777
[TBL] [Abstract][Full Text] [Related]
3. Single-cell RNA sequencing reveals transdifferentiation of parathyroid chief cells into oxyphil cells in patients with uremic secondary hyperparathyroidism.
Mao J; You H; Wang M; Ba Y; Qian J; Cheng P; Lu C; Chen J
Kidney Int; 2024 Mar; 105(3):562-581. PubMed ID: 38142040
[TBL] [Abstract][Full Text] [Related]
4. Differential gene expression by oxyphil and chief cells of human parathyroid glands.
Ritter CS; Haughey BH; Miller B; Brown AJ
J Clin Endocrinol Metab; 2012 Aug; 97(8):E1499-505. PubMed ID: 22585091
[TBL] [Abstract][Full Text] [Related]
5. Paricalcitol and cinacalcet have disparate actions on parathyroid oxyphil cell content in patients with chronic kidney disease.
Ritter C; Miller B; Coyne DW; Gupta D; Zheng S; Brown AJ; Slatopolsky E
Kidney Int; 2017 Nov; 92(5):1217-1222. PubMed ID: 28750928
[TBL] [Abstract][Full Text] [Related]
6. Local NF-κB Activation Promotes Parathyroid Hormone Synthesis and Secretion in Uremic Patients.
Mao J; Wang M; Ni L; Gong W; Jiang X; Zhang Q; Zhang M; Wen D; Chen J
Endocrinology; 2021 Jul; 162(7):. PubMed ID: 33912936
[TBL] [Abstract][Full Text] [Related]
7. Relationship between parathyroid oxyphil cell proportion and clinical characteristics of patients with chronic kidney disease.
Ding Y; Zou Q; Jin Y; Zhou J; Wang H
Int Urol Nephrol; 2020 Jan; 52(1):155-159. PubMed ID: 31686279
[TBL] [Abstract][Full Text] [Related]
8. Increased parathyroid expression of klotho in uremic rats.
Hofman-Bang J; Martuseviciene G; Santini MA; Olgaard K; Lewin E
Kidney Int; 2010 Dec; 78(11):1119-27. PubMed ID: 20631679
[TBL] [Abstract][Full Text] [Related]
9. The induction of C/EBPβ contributes to vitamin D inhibition of ADAM17 expression and parathyroid hyperplasia in kidney disease.
Arcidiacono MV; Yang J; Fernandez E; Dusso A
Nephrol Dial Transplant; 2015 Mar; 30(3):423-33. PubMed ID: 25294851
[TBL] [Abstract][Full Text] [Related]
10. The Emerging Role of Nutritional Vitamin D in Secondary Hyperparathyroidism in CKD.
Lu CL; Yeih DF; Hou YC; Jow GM; Li ZY; Liu WC; Zheng CM; Lin YF; Shyu JF; Chen R; Huang CY; Lu KC
Nutrients; 2018 Dec; 10(12):. PubMed ID: 30513912
[TBL] [Abstract][Full Text] [Related]
11. Are oxyphil cells responsible for the ineffectiveness of cinacalcet hydrochloride in haemodialysis patients?
Rottembourg J; Menegaux F
Clin Kidney J; 2019 Jun; 12(3):433-436. PubMed ID: 31198545
[TBL] [Abstract][Full Text] [Related]
12. Oxyphil cell function in secondary parathyroid hyperplasia.
Tanaka Y; Funahashi H; Imai T; Seo H; Tominaga Y; Takagi H
Nephron; 1996; 73(4):580-6. PubMed ID: 8856255
[TBL] [Abstract][Full Text] [Related]
13. Calcitriol pulse therapy and histology of parathyroid glands in hemodialysis patients.
Lomonte C; Martino R; Selvaggiolo M; Bona RM; Cazzato F; Milano R; Chiarulli G; Basile C
J Nephrol; 2003; 16(5):716-20. PubMed ID: 14733419
[TBL] [Abstract][Full Text] [Related]
14. Dual-specificity phosphatases are implicated in severe hyperplasia and lack of response to FGF23 of uremic parathyroid glands from rats.
Román-García P; Carrillo-López N; Naves-Díaz M; Rodríguez I; Ortiz A; Cannata-Andía JB
Endocrinology; 2012 Apr; 153(4):1627-37. PubMed ID: 22334717
[TBL] [Abstract][Full Text] [Related]
15. The oxyphil cell in abnormal parathyroid glands. A study of 114 cases.
Allen TB; Thorburn KM
Arch Pathol Lab Med; 1981 Aug; 105(8):421-7. PubMed ID: 6894851
[TBL] [Abstract][Full Text] [Related]
16. Analysis of α-klotho, fibroblast growth factor-, vitamin-D and calcium-sensing receptor in 70 patients with secondary hyperparathyroidism.
Latus J; Lehmann R; Roesel M; Fritz P; Braun N; Ulmer C; Steurer W; Biegger D; Ott G; Dippon J; Alscher MD; Kimmel M
Kidney Blood Press Res; 2013; 37(1):84-94. PubMed ID: 23552627
[TBL] [Abstract][Full Text] [Related]
17. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
18. Functional and genetic studies of isolated cells from parathyroid tumors reveal the complex pathogenesis of parathyroid neoplasia.
Shi Y; Hogue J; Dixit D; Koh J; Olson JA
Proc Natl Acad Sci U S A; 2014 Feb; 111(8):3092-7. PubMed ID: 24510902
[TBL] [Abstract][Full Text] [Related]
19. The role of phosphorus in the development of secondary hyperparathyroidism and parathyroid cell proliferation in chronic renal failure.
Slatopolsky E; Dusso A; Brown AJ
Am J Med Sci; 1999 Jun; 317(6):370-6. PubMed ID: 10372836
[TBL] [Abstract][Full Text] [Related]
20. Direct in vitro evidence of the suppressive effect of cinacalcet HCl on parathyroid hormone secretion in human parathyroid cells with pathologically reduced calcium-sensing receptor levels.
Kawata T; Imanishi Y; Kobayashi K; Onoda N; Okuno S; Takemoto Y; Komo T; Tahara H; Wada M; Nagano N; Ishimura E; Miki T; Ishikawa T; Inaba M; Nishizawa Y
J Bone Miner Metab; 2006; 24(4):300-6. PubMed ID: 16816924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
